immune system
• the percentage of B1a B cells in the peritoneum is reduced by about half
|
• there is a selective loss of recirculating follicular phenotype B cells from the perisinusoidal niche of bone marrow
|
• numbers of IgMhiIgDhiCD21hiMZ B cell
precursors (MZP), as well as IgMhiIgDlowCD21hiMZ B cells, are severely reduced in the spleen compared to controls
(J:144035)
• MZP B cells are reduced 10.5 fold and MZ B cells are reduced 23 fold compared to controls
(J:144035)
• Background Sensitivity: unlike mice bred to a C57BL/6J background for an additional 13 generation, mice bred to a C57BL/6NHsd background for only 10 generations exhibit loss of marginal zone B cells compared with wild-type mice
(J:231437)
|
• the percentage of B1b B cells in the peritoneum is increased by over half
|
• Background Sensitivity: unlike mice bred to a C57BL/6J background for an additional 13 generation, mice bred to a C57BL/6NHsd background for only 10 generations exhibit an increase in memory T cells in blood and spleen compared with wild-type mice
|
• T cell numbers are slightly reduced in the thymus and almost 2-fold reduced in the spleen
|
• there is a 2.4 fold decrease in the number of cells in the spleen compared to controls
|
• splenic B cells stimulated with anti-IgM have enhanced calcium influx
• enhanced calcium influx was observed for newly formed B cells, follicular B cells, and marginal zone B cells
|
• B cells proliferate faster than controls with sub-optimal doses of anti-IgM
• the proliferation advantage is diminished with higher doses and/or longer stimulation times possibly from increased rates of apoptosis
|
• IgE levels are significantly higher than in controls
|
• IgG1 levels are significantly higher than in controls
|
• lower levels of antigen-specific IgG2a are present after immunization
|
• IgG2b levels are significantly higher than in controls
• however, lower levels of antigen-specific IgG2b are present after immunization
|
• lower levels of antigen-specific IgG3 are present after immunization
|
• IgM levels are significantly higher than in controls
|
• higher levels of anti-DS DNA antibodies than in controls are found in the sera of mice 20-60 weeks of age
|
• higher levels of anti-histone antibodies than in controls are found in the sera of mice 20-60 weeks of age
|
• higher levels of anti-SS DNA antibodies than in controls are found in the sera of mice 20-60 weeks of age
|
• mutants develop an immune complex-glomerulonephritis
|
hematopoietic system
• the percentage of B1a B cells in the peritoneum is reduced by about half
|
• there is a selective loss of recirculating follicular phenotype B cells from the perisinusoidal niche of bone marrow
|
• numbers of IgMhiIgDhiCD21hiMZ B cell
precursors (MZP), as well as IgMhiIgDlowCD21hiMZ B cells, are severely reduced in the spleen compared to controls
(J:144035)
• MZP B cells are reduced 10.5 fold and MZ B cells are reduced 23 fold compared to controls
(J:144035)
• Background Sensitivity: unlike mice bred to a C57BL/6J background for an additional 13 generation, mice bred to a C57BL/6NHsd background for only 10 generations exhibit loss of marginal zone B cells compared with wild-type mice
(J:231437)
|
• the percentage of B1b B cells in the peritoneum is increased by over half
|
• Background Sensitivity: unlike mice bred to a C57BL/6J background for an additional 13 generation, mice bred to a C57BL/6NHsd background for only 10 generations exhibit an increase in memory T cells in blood and spleen compared with wild-type mice
|
• T cell numbers are slightly reduced in the thymus and almost 2-fold reduced in the spleen
|
• there is a 2.4 fold decrease in the number of cells in the spleen compared to controls
|
• splenic B cells stimulated with anti-IgM have enhanced calcium influx
• enhanced calcium influx was observed for newly formed B cells, follicular B cells, and marginal zone B cells
|
• B cells proliferate faster than controls with sub-optimal doses of anti-IgM
• the proliferation advantage is diminished with higher doses and/or longer stimulation times possibly from increased rates of apoptosis
|
• IgE levels are significantly higher than in controls
|
• IgG1 levels are significantly higher than in controls
|
• lower levels of antigen-specific IgG2a are present after immunization
|
• IgG2b levels are significantly higher than in controls
• however, lower levels of antigen-specific IgG2b are present after immunization
|
• lower levels of antigen-specific IgG3 are present after immunization
|
• IgM levels are significantly higher than in controls
|
renal/urinary system
• mutants develop an immune complex-glomerulonephritis
|
cellular
• B cells proliferate faster than controls with sub-optimal doses of anti-IgM
• the proliferation advantage is diminished with higher doses and/or longer stimulation times possibly from increased rates of apoptosis
|